Inpatient management of hyperglycemia and diabetes

Clinical Diabetes

Volumn 29, Issue 1, 2011, Pages 3-9

  Magaji, Vasudev ^a   Johnston, Jann M ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MERCY HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AMYLIN; GLUCAGON LIKE PEPTIDE 1; GLUCOCORTICOID; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN; SULFONYLUREA;

ARTICLE; BODY WEIGHT; CALORIC INTAKE; COMPETITIVE INHIBITION; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DEHYDRATION; DIABETES MELLITUS; DIABETIC PATIENT; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; ENTERIC FEEDING; ERYTHROCYTE TRANSFUSION; FLUID RETENTION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INSULIN TREATMENT; LENGTH OF STAY; LOW DRUG DOSE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; SIDE EFFECT; THERAPY EFFECT; TOTAL PARENTERAL NUTRITION; TREATMENT PLANNING;

EID: 78951472575     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.29.1.3     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention: Crude and age-adjusted percentage of civilian, noninstitutionalized population with diagnosed diabetes, United States, 1980-2008 [article online]. Available from http://www.cdc.gov/diabetes/statistics/prev/national/figage.htm. Accessed July 2010
2. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE: Unrecognized diabetes among hospitalized patients. Diabetes Care 21:246-249, 1998
3. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471-1478, 2003
4. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML: Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 37:3001-3009, 2009
5. American Diabetes Association: Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31:596-615, 2008
6. American Association of Clinical Endocrinologists and American Diabetes Association: Consensus statement on inpatient glucose control. Endocr Pract 15:353-369, 2009
7. The International Expert Committee: International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327-1334, 2009
8. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R: Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 Trial). Diabetes Care 30:2409-2410, 2007
9. Polonsky KS, Given BD, Van Cauter E: Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 81:442-448, 1988
10. Raskin P, Klaff L, Bergenstal R, Hallé JP, Donley D, Mecca T: A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care 23:1666-1671, 2000
11. Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA; U.S. Study Group of Insulin Glargine in Type 1 Diabetes: Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 23:639-643, 2000
12. Porcellati F, Rossetti P, Busciantella NR, Marzotti S, Lucidi P, Luzio S, Owens DR, Bolli GB, Fanelli CG: Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study. Diabetes Care 30:2447-2452, 2007
13. Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L: Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care 23:583-588, 2000
14. Garg S, Ampudia-Blasco FJ, Pfohl M: Rapid-acting insulin analogues in basal-bolus regimens in type 1 diabetes mellitus. Endocr Pract 16:486-505, 2010
15. Bode BW: Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Clin Ther 29 (Suppl. D):S135-S144, 2007
16. Schnipper JL, Ndumele CD, Liang CL, Pendergrass ML: Effects of a subcutaneous insulin protocol, clinical education, and computerized order set on the quality of inpatient management of hyperglycemia: results of a clinical trial. J Hosp Med 4:16-27, 2009
17. Maynard G, Lee J, Phillips G, Fink E, Renvall M: Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med 4:3-15, 2009
18. Donihi AC, DiNardo MM, DeVita MA, Korytkowski MT: Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. Qual Saf Health Care 15:89-91, 2006
19. Davidson PC, Hebblewhite HR, Bode BW, Steed RD, Welch NS, Greenlee MC, Richardson PL, Johnson J: Statistically based CSII parameters: correction factor (CF) (1700 rule), carbohydrate-insulin ratio (CIR) (2.8 rule), and basal-to-total ratio. Diabetes Technol Ther 5:237, 2003
20. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Foten HS, Starr A: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:1007-1021, 2003
21. NICE-SUGAR Study Investigators: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297, 2009
22. Wiener RS, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults. JAMA 300:933-944, 2008
23. Magaji V, Marina A, Mohatasebi Y, Johnston JM: Safety and efficacy of insulin infusion in surgical patients in the non-critical care setting [Abstract No. 218]. Presented at the American Association of Clinical Endocrinologists annual meeting, Houston, Tex., May 11-13, 2009
24. Nazer LH, Chow SL, Moghissi ES: Insulin infusion protocols for critically ill patients: a highlight of differences and similarities. Endocr Pract 13:137-146, 2007
25. Schmeltz LR, DeSantis AJ, Schmidt K, O'Shea-Mahler E, Rhee C, Brandt S, Peterson S, Molitch ME: Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract 12:641-650, 2006
26. Bode BW, Braithwaite SS, Steed RD, Davidson PC: Intravenous insulin infusion therapy: indications, methods and transition to subcutaneous insulin therapy. Endocr Pract 10 (Suppl. 2):71-80, 2004
27. Krikorian A, Ismail-Beigi F, Moghissi ES: Comparisons of different insulin infusion protocols: a review of recent literature. Curr Opin Clin Nutr Metab Care 13:198-204, 2010
28. Pancorbo-Hidalgo PL, Garcia-Fernandez FP, Ramirez-Perez C: Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit. J Clin Nurs 10:482-490, 2001
29. Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ: Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care 28:2267-2279, 2005
30. Korytkowski MT, Salata RJ, Koerbel GL, Selzer F, Karslioglu E, Idriss AM, Lee KK, Moser AJ, Toledo FG: Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy. Diabetes Care 32:594-596, 2009
31. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB: Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27:553-591, 2004
32. Leahy JL: Insulin management of diabetic patients on general medical and surgical floors. Endocr Pract 12 (Suppl. 3):86-90, 2006
33. Cheung NW, Napier B, Zaccaria C, Fletcher JP: Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care 28:2367-2371, 2005
34. American Diabetes Association: Standards of medical care in diabetes-2010. Diabetes Care 33 (Suppl. 1):S11-S61, 2010
35. Noschese M, Donihi A, Curll M, DiNardo M, Koerbel G, Karslioglu E, Banks T, Korytkowski M: The effect of a diabetes order set on glycaemic management and control in the hospital. Qual Saf Health Care 17:464-468, 2008